Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer

Obesity and diabetes have been associated with increased risk and worse outcomes in ovarian cancer (OC). The biguanide metformin is used in the treatment of type 2 diabetes and is also believed to have anti-tumorigenic benefits. Metformin is highly hydrophilic and requires organic cation transporter...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Amanda L., Sun, Wenchuan, Kilgore, Joshua, Guo, Hui, Fang, Ziwei, Yin, Yajie, Jones, Hannah M., Gilliam, Timothy P., Zhou, Chunxiao, Bae-Jump, Victoria L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725006/
https://www.ncbi.nlm.nih.gov/pubmed/29245964
http://dx.doi.org/10.18632/oncotarget.22012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725006/
https://www.ncbi.nlm.nih.gov/pubmed/29245964
http://dx.doi.org/10.18632/oncotarget.22012

Ejemplares similares